欢迎参加 Phoenix Cloud 即将推出的表格、数字和列表 (TFL) 模块独家抢先体验。Discover how this innovative tool will revolutionize the way you create and manage TFLs, providing faster results, enhanced flexibility, and streamlined collaboration. During this webinar, you’ll explore key features such as: This webinar is perfect for … <a href="https://www.certara.com.cn/webinar/sneak-preview-introducing-the-new-tfl-module-in-phoenix-cloud/">Continued</a>
The Centers for Medicare & Medicaid Services (CMS) is piloting a program that would negotiate and administer outcome-based agreements and supplemental rebates on behalf of state Medicaid agencies The CGT Access model will initially focus on gene therapy for sickle cell disease On 2024 年 12 月 4 日, CMS announced that it had successfully negotiated contracts with … Continued
What is a “cell therapy”? Nearly every recent oncology clinical conference has featured this phrase. Cell therapies, such as CAR-Ts (chimeric antigen receptor T-cells), aren’t small molecule drugs or simple biologics. They’re a whole new class of therapeutics! How does CAR-T technology work? In simple terms, it’s a method for enabling our immune system to … Continued
The Standard for Exchange of Nonclinical Data (SEND) is a standardized, electronic format for exchanging nonclinical drug development data. SEND was developed by the Clinical Data Interchange Standards Consortium (CDISC), a globally recognized, not-for-profit organization that develops data standards with the input of pharmaceutical industry experts. The U.S. Food and Drug Administration (FDA) requires drug … Continued
Certara 提供先进的药物开发解决方案，帮助制药和生物技术公司加快从早期研究到成功获得市场批准的过程。Certara 的专家团队中不乏世界领先的科学家，其中有七位科学家在他们各自的领域中被公认为被引用次数最多的前 2% 的科学家*。我们带给客户的价值在于与业内规模最大的模型引导的药物开发团队合作，降低项目风险，缩短时间线，降低成本，并提高对新的疗法如何影响患者的科学理解。Certara 拥有灵活的操作模式，支持大型制药企业中的专业建模团队，并为新兴生物科技初创公司担任全面的药物开发管理者，为客户提供卓越的价值，助您快速前进。
Certara 软件产品包括行业黄金标准产品，已在全球超过 60,000 名最终用户中使用。我们的目标是利用先进的计算能力引领行业，改变药物开发模型，包括药物发现、生物模拟和临床数据自动化。
全球有超过 2,300 家生命科学公司，包括 23 家全球监管机构，选择 Certara 作为他们在 MIDD 解决方案方面的合作伙伴，这些解决方案包括生物模拟、数据科学软件和专业的药物开发服务。了解我们如何帮助公司重新定义现代医学的可能。
